Introduction {#s1}
============

Since the discovery of the (GGGGCC)~n~ repeat expansion in *C9orf72* in about 10% of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia patients, several potential pathomechanisms have been proposed ([@bib9]). The repeat RNA is clustered in nuclear foci in neurons and non-neuronal tissues in patients, without apparent correlation with neuron loss ([@bib7]). Several proteins binding to the repeat RNA have been identified, but up to now their role in pathogenesis is still unclear. Furthermore, sense and antisense transcripts of the repeat are translated into five dipeptide repeat (DPR) proteins that co-aggregate in predominantly neuronal cytoplasmic inclusions in *C9orf72* patients: poly-GA, poly-GP, poly-GR, poly-PR, and poly-PA. Although several groups failed to detect a direct correlation of DPR expression with neurodegeneration ([@bib20], [@bib21]; [@bib31]), a recent report identified dendritic poly-GR pathology specifically in the motor cortex of ALS patients ([@bib29]), although it is unclear how the conflicting findings can be explained. Therefore, the role of the DPR proteins in disease pathogenesis is still under intense debate.

Individual expression of poly-(Gly-Arg) and poly-(Pro-Arg) (poly-GR/PR) is highly toxic in various model systems ([@bib16]; [@bib23]; [@bib40]; [@bib13]; [@bib2]; [@bib17]; [@bib18]; [@bib19]), but poly-GR and especially poly-PR show predominantly nucleolar localization in most in vitro systems, which is not observed in patient tissue ([@bib31]). Genetic screens for poly-PR toxicity have highlighted a link to nucleocytoplasmic transport ([@bib13]; [@bib2]), whereas poly-GR seems to predominantly affect other pathways in yeast ([@bib3]). Recently, poly-GR/PR have been shown to undergo phase separation in vitro and interact with low-complexity domain proteins in membrane-less organelles, specifically in the nucleolus and stress granules ([@bib17]; [@bib18]; [@bib1]). Poly-GR/PR--interacting proteins have been analyzed using pull-down experiments with short peptides that spontaneously phase-separate together with proteins and RNA from the cell extracts ([@bib14]; [@bib18]; [@bib1]; [@bib41]) or using expression of short repeat constructs ([@bib17]; [@bib19]). In contrast to several poly-GA--interacting proteins ([@bib22]; [@bib42]; [@bib30]), none of the reported poly-GR/PR interactors has been validated in patient tissue. Poly-GR/PR toxicity has also been linked to altered splicing ([@bib16]; [@bib41]), reduced translation ([@bib14]), ER stress ([@bib15]), and mitochondrial stress ([@bib19]), but it is unclear which effects are relevant in patients. The severe toxicity in some model systems is hard to reconcile with the prodromal expression at least of poly-GR many years before disease onset ([@bib38]). Therefore, current models likely exaggerate toxicity although it is possible that cytoplasmic poly-GR/PR inclusions trigger similar pathways in vivo with milder effects.

To elucidate the functional consequences of poly-GR/PR expression in patients, we analyzed the interactomes of poly-GR and poly-PR in primary neurons and HEK293 cells and validated candidate proteins in cellular systems and patient tissue, focusing on stress granules, the nucleolus, and ribosomes. Overexpression of several interactors recruits poly-GR/PR into large cytoplasmic stress granule--like structures. Moreover, acute neurotoxicity of poly-GR/PR requires nucleolar localization and is associated with reduced levels of ribosomes and impaired translation. Importantly, we could validate co-aggregation of ribosomes in cytosolic DPR inclusions in patient brain tissue, supporting a primary role of translational inhibition for poly-GR/PR toxicity in vivo.

Results {#s2}
=======

Poly-GR and poly-PR interact with ribosomes, stress granules, and low-complexity proteins {#s3}
-----------------------------------------------------------------------------------------

To identify which poly-GR and poly-PR interactors would be most relevant for neurodegeneration in *C9orf72* patients, we analyzed the poly-GR/PR interactomes in rat primary cortical neurons and HEK293 cells. Consistent with previous results ([@bib31]), lentiviral expression with GFP-(GR)~149~ in neurons resulted in predominantly diffuse cytoplasmic expression and some nucleolar localization, whereas (PR)~175~-GFP was mostly localized to the nucleolus ([Fig S1A and B](#figS1){ref-type="fig"}). Fusion with nuclear export signals or (GA)~50~ failed to shift poly-PR quantitatively to the cytoplasm (data not shown). In HEK293 cells, (PR)~175~-GFP also mainly localized to the nucleolus, whereas GFP-GFP-(GR)~149~ was found in both nucleolus and cytoplasm. In contrast to previous reports, only (PR)~175~-GFP, but not GFP-(GR)~149~, induced significant cell death in neurons compared with the GFP control as measured by an LDH release assay ([Fig S1C](#figS1){ref-type="fig"}). However, both (PR)~175~-GFP and GFP-(GR)~149~ impaired the growth of HEK293 cells as shown by the XTT assay, which measures mitochondrial activity ([Fig S1D](#figS1){ref-type="fig"}) but did not trigger significant cell death as reported previously ([@bib22]). Overall, these observations suggest that nucleolar localization may be important for poly-GR/PR toxicity in vitro.

![Characterization of DPR proteins in primary rat neurons and HEK293 cells.\
GFP, GFP-(GR)~149~, or (PR)~175~-GFP were expressed in primary rat neurons and HEK293 cells. **(A)** Images show GFP fluorescence of a single confocal plane in cells stained with DAPI to visualize nuclei and anti-fibrillarin (red) to visualize nucleoli. Scale bar denotes 20 μm. **(B)** Quantitative analysis of poly-GR/PR localization to fibrillarin-positive nucleoli. Average co-localization from n = 17 for GFP-(GR)~149~, n = 13 for (PR)~175~-GFP images in neurons and n = 6 for GFP-(GR)~149~, n = 6 for (PR)~175~-GFP images in HEK cells from two independent experiments, mean ± SEM is shown. **(C)** LDH release assay detects significant toxic effect on (PR)~175~-GFP but not GFP-(GR)~149~ expression compared with GFP control in primary rat neurons (DIV7 + 14) (18 replicates from three independent experiments; box plot is shown with 25th percentile, median, and 75th percentile; and whiskers representing minimum and maximum, exact *P*-values: GFP versus GFP-GR~149~, *P* = 0.9583 and GFP versus PR~175~-GFP; *P* = 0.0001 in unpaired one-way ANOVA with Dunnett's posttest). **(D)** Cell viability of HEK293 cells transfected with GFP, GFP-(GR)~149~, or (PR)~175~-GFP measured by XTT assay 3 days after transfection. GFP-(GR)~149~ and (PR)~175~-GFP showed significantly reduced viability compared with GFP control (12 replicates from two independent experiments; box plot is shown, exact *P*-values: GFP versus GFP-GR~149~, *P* = 0.0001 and GFP versus PR~175~-GFP, *P* = 0.0001 in unpaired one-way ANOVA with Dunnett's posttest).](LSA-2018-00070_FigS1){#figS1}

For the interactome analysis from primary neurons and HEK293 cells, we immunoprecipitated GFP-(GR)~149~, (PR)~175~-GFP, and a GFP control using GFP antibodies and analyzed the interactome using quantitative mass spectrometry. In primary neurons, we quantitatively compared close to 600 proteins (Table S1A). Among those, we identified 89 poly-GR and 104 poly-PR interactors ([Fig S2A](#figS2){ref-type="fig"}), of which ∼60% are annotated as RNA-binding proteins ([@bib11]). Both DPR proteins interact with numerous components of ribosomes, the nucleolus, and stress granules ([@bib12]) as well as proteins involved in splicing. 39 proteins were commonly enriched in both interactomes ([Fig 1A](#fig1){ref-type="fig"}). Consistent with previous data, sequence analysis of poly-GR/PR interactors shows enrichment of proteins with low-complexity domains ([Fig 1B](#fig1){ref-type="fig"}).

Table S1 **(A)** Proteomics raw data for the interactome and whole proteome of GFP-(GR)~149~-GFP, (PR)~175~-GFP, and GFP expressing primary cortical neurons from rat. **(B)** Proteomics raw data for the interactome of GFP-(GR)~149~-GFP, (PR)~175~-GFP, and GFP expressing HEK293 cells.

![Poly-GR and poly-PR interact with overlapping proteins in primary neurons and in HEK293 cells.\
Quantitative proteomics of GFP immunoprecipitations from HEK293 cells and primary rat neurons transfected or transduced with GFP, GFP-(GR)~149~, or (PR)~175~-GFP. **(A, B)** Volcano plots of interactomes from neurons (A) and HEK293 cells (B). The data for all proteins are plotted as log~2~-fold change versus the −log~10~ of the *P-*value. Gray line indicates significance cutoff. Enriched protein families are color coded: cytoplasmic ribosome (blue), mitochondrial ribosome (red), stress granules (brown) ([@bib12]), and methylosome (green). The top enriched proteins (sorted by fold-change) and the proteins analyzed in this study are labeled with gene names. Filled circles indicated that the protein was significantly altered in the other cell type.](LSA-2018-00070_FigS2){#figS2}

![Poly-GR and poly-PR interact with similar low-complexity proteins in neurons.\
Quantitative proteomics of GFP immunoprecipitations from primary cortical neurons transduced with GFP, GFP-(GR)~149~, or (PR)~175~-GFP (DIV7 + 8). The complete dataset is available in Table S1. **(A)** Proteins with significant enrichment in poly-GR/PR interactomes compared with GFP control were manually grouped into functional categories. Orthologues of proteins in italics were also found in the poly-GR/PR interactomes from HEK293 cells. Underlined proteins are analyzed in this paper. **(B)** Proportion of low-complexity regions (IUPred-L) of all proteins identified in the neuronal interactome analysis, the poly-GR interactome, and the poly-GR interactome. Significance of difference was assessed with the Mann--Whitney--Wilcoxon test, exact *P*-values: GFP versus GFP-(GR)~149~, *P* = 0.004566 and GFP versus (PR)~175~-GFP, *P* = 0.001656. Whiskers extend to ±1.5 box height (i.e., total three times the interquartile range). **(C)** 2D analysis of GO enrichment terms (GOMF, GOCC, GOCC, GOPB, KEGG, and UniProt keywords) and stress granule proteins ([@bib12]) for proteins found in the poly-GR and poly-PR interactome in primary neurons and HEK293 cells ([Fig S2](#figS2){ref-type="fig"} and Tables S1 and S2). Some dots with nearly identical position and annotation were removed for clarity. Related terms from the main enriched pathways are labeled in the same color. Annotation terms with a Benjamini--Hochberg FDR (q*-*value) \<0.1 and comprising at least six proteins quantified by mass spectrometry are shown. 1D annotation scores close to 1 indicate strongest enrichment over the GFP control, scores close to 0 indicate no enrichment, and scores close to --1 indicate strongest depletion. The analysis was performed in Perseus software ([@bib37]).](LSA-2018-00070_Fig1){#fig1}

For comparison, we additionally analyzed the poly-GR/PR interactome from HEK293 cells, resulting in 394 proteins enriched exclusively in poly-GR and 49 proteins enriched in both poly-GR and poly-PR ([Fig S2B](#figS2){ref-type="fig"} and Table S1B). Only one protein (CD2AP) was solely enriched in the poly-PR interactome. In total, about 80% of the interactors are annotated as RNA-binding proteins ([@bib11]). Overall, there was a consistent overlap with published data ([@bib17]; [@bib18]; [@bib1]).

Comparison of the gene ontology (GO) terms enriched in the poly-GR/PR interactors in primary neurons and HEK293 cells showed a strong selectivity for proteins related to ribosomes, stress granules, the nucleolus, the spliceosome, and the methylosome (mediating arginine methylation) in the poly-GR interactome ([Fig 1B](#fig1){ref-type="fig"} and Table S2). Interaction of PRMT1/5 with poly-GR, but not poly-PR, suggests that only poly-GR is arginine methylated ([@bib31]). Poly-PR interactors were most strongly enriched in proteins of the U1 and U4 small nuclear RNP, the exon--exon junction complex and mitochondrial ribosomes in both cell types. Although several cytosolic ribosomal proteins were enriched in the (PR)~175~-GFP immunoprecipitates in neurons ([Fig S2A](#figS2){ref-type="fig"}), several other subunits were depleted, which may be explained by the overall reduction of cytosolic ribosomal proteins in poly-PR--expressing neurons, whereas mitochondrial ribosomal proteins are even found at higher levels ([Figs 5B](#fig5){ref-type="fig"} and [S6B](#figS6){ref-type="fig"}).

Table S2 **(A)** Enrichment of GO terms in the GFP-(GR)~149~ interactors in primary neurons and HEK293 cells. **(B)** Enrichment of gene ontology (GO) terms in the (PR)~175~-GFP interactors in primary neurons and HEK293 cells.

Table S3 **(A)** Enrichment of GO terms in proteome comparisons of (PR)~175~-GFP and GFP transduced primary neurons. (**B**) Enrichment of gene ontology (GO) terms in proteome comparisons of (PR)~175~-GFP and GFP transduced primary neurons.

In summary, poly-GR/PR interact preferentially with RNA-binding proteins. For the functional analysis, we focused on the interaction of poly-GR/PR with the nucleolus, stress granules, and the ribosome and compared findings from overexpression of several interactors in cultured cells with patient tissue.

NPM1 traps poly-GR into the nucleolus {#s4}
-------------------------------------

To functionally validate putative poly-GR/PR--interacting proteins and get a better understanding of their role in DPR toxicity, we co-expressed RFP-tagged interactors together with GFP-(GR)~149~, (PR)~175~-GFP, or control GFP in HEK293 cells and neurons and analyzed the localization of the DPR proteins and the interacting proteins.

First, we tested the nucleolar proteins NOP56 and NPM1, which we identified as interactors in both cell types ([Fig 1A](#fig1){ref-type="fig"} and Table S1). As expected, RFP-NOP56 and RFP-NPM1 co-localized with poly-GR and poly-PR predominantly in the nucleolus in HEK293 cells ([Fig S3](#figS3){ref-type="fig"}). In primary neurons, GFP-(GR)~149~ was largely absent from the nucleolus ([Fig 2A](#fig2){ref-type="fig"}). However, expression of RFP-NPM1 surprisingly recruited cytoplasmic GFP-(GR)~149~ into the nucleolus resulting in co-localization in almost all cells ([Fig 2B and D](#fig2){ref-type="fig"}). In contrast, poly-GR localized predominantly to the cytosol in RFP-NOP56--transduced neurons, similar to the RFP control ([Fig 2A, C, and D](#fig2){ref-type="fig"}). Poly-PR co-localized with RFP-NOP56, but co-expression altered the distribution of RFP-NOP56 within the nucleolus compared with GFP or GFP-(GR)~149~ ([Fig 2C](#fig2){ref-type="fig"}, close-up in right column). Although RFP-NOP56 is evenly distributed in the nucleolus under control conditions in neurons, it showed a granular pattern in poly-PR--expressing cells, which is consistent with the poly-PR--specific interaction of NOP56 in neurons ([Fig 1A](#fig1){ref-type="fig"}). Thus, the interaction of poly-GR/PR with nucleolar proteins has sufficient affinity to alter the subcellular distribution of either binding partner.

![Nucleolar interactors co-localize with poly-GR/PR in HEK293 cells.\
**(A--C)** HEK293 cells co-expressing RFP-tagged nucleolar interactors NPM1 and NOP56 with GFP, GFP-(GR)~149~, or (PR)~175~-GFP in single focal planes were analyzed. DAPI was used as nuclear marker and the scale bar depicts 20 μm. RFP was used as negative control. Left columns show GFP signal, middle columns RFP-tagged proteins, and right columns show merge of GFP, RFP-tagged proteins, and nuclear DAPI staining (blue). Note that HEK293 cells show co-localization of NPM1 and NOP56 with poly-GR and poly-PR in nucleoli (white arrows). Red arrow indicates cytoplasmic granules occasionally seen in poly-GR/PR--expressing cells.](LSA-2018-00070_FigS3){#figS3}

![NPM1 drives poly-GR into the nucleolus of primary neurons.\
Primary rat neurons (DIV7 + 7) were cotransduced with RFP-tagged nucleolar interactors NPM1 and NOP56 with GFP, GFP-(GR)~149~, or (PR)~175~-GFP. **(A--C)** Single focal planes obtained by confocal microscopy are shown. DAPI was used as nuclear marker and the scale bar depicts 20 μm. RFP was used as negative control. Left columns show GFP signal, middle columns show RFP-tagged proteins, and right columns show merge of GFP, RFP-tagged proteins, and nuclear DAPI staining (blue). RFP-NPM1 and RFP-NOP56 are co-localizing with poly-PR. Note that NPM1 expression recruits poly-GR into the nucleolus (red arrow). Poly-PR--expressing neurons show altered NOP56 nucleolar staining (single channel shown in zoom). **(D)** Fraction of cells with poly-GR localized to the nucleolus in NPM1-- and NOP56--expressing neurons compared with the RFP control (RFP, n = 9; RFP-NPM1, n = 11; and RFP-NOP56, n = 10 images (40× objective) from three independent experiments, mean ± SEM, exact *P*-values: RFP versus RFP-NPM1, *P* = 0.0001 and RFP versus RFP-NOP56, *P* = 0.2307 in one-way ANOVA with Dunnett's posttest).](LSA-2018-00070_Fig2){#fig2}

STAU1/2 and YBX1 reroute poly-GR/PR into large cytoplasmic granules {#s5}
-------------------------------------------------------------------

The poly-GR/PR interactomes contain many stress granule--related proteins, but only a small fraction of transfected cells shows small cytoplasmic poly-GR/PR granules (arrows in [Fig S3A](#figS3){ref-type="fig"}). However, expression of several RNA-binding proteins from the poly-GR/PR interactome promoted cytoplasmic clustering of the two DPR protein species in HEK293 cells. Most strikingly, STAU1/2 and YBX1 rerouted both poly-GR and poly-PR into cytoplasmic clusters that can be quite large ([Fig 3A](#fig3){ref-type="fig"}) and are reminiscent of the cytoplasmic poly-GR/PR inclusions seen in patients ([@bib25], [@bib26]). In contrast, we did not detect any differences with the stress granule--associated poly-PR interactor EIF4A3 ([Fig 3A and B](#fig3){ref-type="fig"}). Quantitative analysis showed that the average size and also the number of cytoplasmic poly-GR/PR inclusions are strongly increased upon expression of RFP-STAU1/2 and RFP-YBX1 but not RFP-EIF4A3 ([Fig 3B](#fig3){ref-type="fig"}).

![STAU1/2 and YBX1 recruit poly-GR/PR into large cytoplasmic granules.\
HEK293 cells and primary cortical neurons were co-transfected with GFP, GFP-(GR)~149~, or (PR)~175~-GFP expression vectors and RFP-tagged interactors associated with stress granules. **(A)** Immunofluorescence images of HEK293 cells showing co-expression of RFP-STAU1/2, RFP-YBX1, or RFP-EIF4A3 together with GFP-(GR)~149~, (PR)~175~-GFP, or GFP. STAU1/2 and YBX1 reroute poly-GR and poly-PR into large cytoplasmic structures (white arrows). Left columns show GFP signal, right columns show merge of GFP, RFP-tagged proteins, and nuclear DAPI staining (blue). Scale bar denotes 20 μm. **(B)** Quantifications of cytoplasmic poly-GR/PR granules from (A). Left bar graph shows percentage of cytoplasmic granules out of all granules (in nucleolus and cytoplasm) in poly-GR (red bars) and poly-PR (blue bars) (GR/RFP, n = 16 images (40×) from two independent experiments: PR/RFP, n = 14; GR/RFP-STAU1, n = 19; PR/RFP-STAU1, n = 20; GR/RFP-STAU2, n = 10; PR/RFP-STAU2, n = 8; GR/RFP-YBX1, n = 14; PR/RFP-YBX1, n = 14; GR/RFP-EIF4A3, n = 6; and PR/RFP-EIF4A3, n = 6). Cytoplasmic granule size is represented by the right bar graph (GR/RFP, n = 130 aggregates from two individual experiments; PR/RFP, n = 132; GR/RFP-STAU1, n = 104; PR/RFP-STAU1, n = 132; GR/RFP-STAU2, n = 123; PR/RFP-STAU2, n = 65; GR/RFP-YBX1, n = 119; PR/RFP-YBX1, n = 53; GR/RFP-EIF4A3, n = 93; and PR/RFP-EIF4A3, n = 71). Mean ± SEM is shown, exact *P*-values for left graph: GR/RFP-STAU1 versus GR/RFP, *P* = 0.0001; GR/RFP-STAU2 versus GR/RFP, *P* = 0.0001; GR/RFP-YBX1 versus GR/RFP, *P* = 0.0001; GR/RFP-EIF4A3 versus GR/RFP, *P* = 0.0775; PR/RFP-STAU1 versus PR/RFP, *P* = 0.9999; PR/RFP-STAU2 versus PR/RFP, *P* = 0.0007; PR/RFP-YBX1 versus PR/GFP, *P* = 0.7820; PR/RFP-EIF4A3 versus PR/RFP, *P* = 0.3936; exact *P*-values for right graph: GR/RFP-STAU1 versus GR/RFP, *P* = 0.0001; GR/RFP-STAU2 versus GR/RFP, *P* = 0.0001; GR/RFP-YBX1 versus GR/RFP, *P* = 0.0023; GR/RFP-EIF4A3 versus GR/RFP, *P* = 0.9672; PR/RFP-STAU1 versus PR/RFP, *P* = 0.0001; PR/RFP-STAU2 versus PR/RFP, *P* = 0.0001; PR/RFP-YBX1 versus PR/RFP, *P* = 0.0023; and PR/RFP-EIF4A3 versus PR/RFP, *P* = 0.8492 in one-way ANOVA with Dunnett's posttest. **(C)** Immunofluorescence images of transfected neurons (DIV7 + 3) co-expressing RFP-STAU1, RFP-STAU2, or RFP-YBX1, and GFP-(GR)~149~ or GFP obtained by confocal microscopy are shown. Top row shows GFP signal, middle row shows RFP-tagged interactor or RFP control, and bottom row shows merge including nuclear DAPI (blue). Comparison of the largely homogenous poly-GR pattern in the RFP with punctate distribution in neurons co-expressing RFP-STAU1/2 and YBX1.](LSA-2018-00070_Fig3){#fig3}

Using transient co-transfection to allow higher expression levels in primary neurons, we detected similar co-localization of GFP-(GR)~149~ with RFP-STAU1/2 and RFP-YBX1 in cytoplasmic clusters ([Fig 3C](#fig3){ref-type="fig"}) but not for RFP-EIF4A3 (data not shown). Presumably because of even higher toxicity, we did not detect (PR)~175~-GFP--expressing neurons upon transfection. Thus, the interaction with several stress granule--associated proteins recruits poly-GR/PR into large cytoplasmic granules resembling the neuronal cytoplasmic inclusions seen in *C9orf72* patients.

Cytoplasmic poly-GR/PR clusters resemble stress granules {#s6}
--------------------------------------------------------

To elucidate the nature of these cytoplasmic poly-GR/PR clusters, we probed HEK293 cells co-transfected with RFP-STAU1 and poly-GR/PR with the stress granule marker G3BP1 and detected striking co-localization and sequestration of G3BP1 into the poly-GR/PR granules ([Fig 4A](#fig4){ref-type="fig"}). Without co-expression of RNA-binding proteins, the less frequent cytoplasmic poly-GR/PR punctae were predominantly G3BP1 positive, indicating that overexpression of STAU1/2 and YBX1 enhances a normal process that may ultimately lead to aggregation of poly-GR/PR in patients (compare [Fig 3B](#fig3){ref-type="fig"}), which is consistent with the interaction with stress granule proteins under basal conditions ([Fig 1](#fig1){ref-type="fig"}).

![Cytoplasmic poly-GR/PR inclusions resemble stress granules in vitro.\
Immunofluorescence of stress granule markers in HEK293 cells and patient brain. DAPI visualizes nuclei. Single confocal planes were taken. Scale bar depicts 20 μm. **(A)** Co-localization of poly-GR/PR with the stress granule marker G3BP1 in HEK293 cells co-transfected with RFP-STAU1 or RFP control and DPR-GFP or GFP control. Left three columns show individual channels as indicated. The fourth columns show merge with additional nuclear DAPI staining in white. Arrows indicate cytoplasmic inclusions co-labeled with G3BP1. **(B)** Immunofluorescence of frontal cortex of a *C9orf72* patient and a healthy control case to analyze co-localization of poly-GR with stress granule components TIAR, G3BP2, YBX1, and STAU2. Arrows indicate poly-GR aggregates.\
Source data are available for this figure.](LSA-2018-00070_Fig4){#fig4}

Then, we wondered whether poly-GR/PR inclusions in patients could be labeled by stress granule markers and compared an frontotemporal lobar degeneration case with *C9orf72* repeat expansion with a healthy control case by double immunofluorescence. As expected, the *C9orf72* frontotemporal lobar degeneration case showed widespread poly-GR and sparse poly-PR cytoplasmic inclusions in the frontal cortex. We detected not a single poly-GR/PR inclusion convincingly co-localizing with classical stress granule markers proteins (G3BP2 and TIAR) and the interactor YBX1 in two *C9orf72* patients. However, ∼25 % of poly-GR inclusions (76 of 300 counted aggregates) were co-stained with STAU2 in cortex ([Fig 4B](#fig4){ref-type="fig"}).

In conclusion, despite interaction of poly-GR/PR with many stress granule--related proteins and recruitment of poly-GR/PR into stress granules on overexpression of STAU1/2 and YBX1, classical stress granule marker proteins are not readily detectable in the poly-GR inclusions in postmortem brains of *C9orf72* patients, suggesting a more transient interaction.

Poly-GR/PR inclusions in patients contain ribosomes {#s7}
---------------------------------------------------

Because the ribosomal proteins are very prominent in the poly-GR/PR interactomes, we additionally analyzed the localization of the 40S protein RPS6 in poly-GR/STAU1--co-transfected HEK293 cells ([Fig S4A](#figS4){ref-type="fig"}). Unlike for stress granule markers, we detected only modest amounts of RPS6 in poly-GR/PR inclusions without strong enrichment compared with the cytoplasm.

![Poly-GR mainly co-localizes with nucleolar ribosomes.\
**(A)** HEK293 cells were co-transfected with GFP, GFP-(GR)~149~, or (PR)~175~-GFP expression vectors and RFP-STAU1 as in [Fig 3A](#fig3){ref-type="fig"} and endogenous RPS6 detected by immunofluorescence. Note that the large cytoplasmic poly-GR/PR granules induced by STAU1 expression are not clearly stained with the ribosomal subunit compared with the cytoplasm. Merge shows additionally DAPI in gray. Single confocal planes are shown. Scale bar denotes 20 μm. **(B)** Frontal cortex of a *C9orf72* patient and a control brain were co-stained for poly-GR and ribosomal proteins as in [Fig 5A](#fig5){ref-type="fig"}. RPS25 and RPL36A are partially sequestered into poly-GR inclusions. DAPI visualizes nuclei. Single confocal planes are shown. Scale bar depicts 20 μm. **(C)** Quantification of GR aggregates co-localizing with ribosomal proteins (n = 3 cortical sections with 100 GR aggregates counted each from two different patients; mean ± SEM is shown).](LSA-2018-00070_FigS4){#figS4}

We did not analyze individual ribosomal proteins using the co-expression approach because tagging the ribosome is notoriously difficult. Instead, we directly analyzed the localization of several ribosomal proteins with good available antibodies directly in patient brain. Compared with controls, several ribosomal subunits (RPS6, RPS25, RPL19, and RPL36A) were enriched in both poly-GR and, less strikingly, also in poly-PR inclusions ([Figs 5A](#fig5){ref-type="fig"} and [S4B](#figS4){ref-type="fig"}). Quantification shows that approximately one third of GR inclusions show co-localization with ribosomal proteins in cortex ([Figs 5B](#fig5){ref-type="fig"} and [S4C](#figS4){ref-type="fig"}). However, most neurons showed robust residual ribosome staining in the cytoplasm.

![Poly-GR and poly-PR co-aggregate with ribosomal proteins in *C9orf72* patients.\
**(A)** Immunofluorescent stainings of components of the small (RPS6) and large (RPL19) ribosomal subunits in *C9orf72* patient brains and controls. Additional ribosomal proteins are shown in [Fig S4B](#figS4){ref-type="fig"}. Note the enrichment of ribosomal proteins in poly-GR/PR inclusions. DAPI marks nuclei in blue. Single confocal planes were taken. Scale bar depicts 20 μm. **(B)** Quantitative analysis of co-localization of ribosomal proteins with poly-GR aggregates (n = 3 sections with 100 poly-GR aggregates counted each from *C9orf72* cortex, mean ± SEM is shown).](LSA-2018-00070_Fig5){#fig5}

Moreover, we extensively tested co-aggregation of poly-GR/PR with other interactors identified in vitro. From 22 tested proteins, six showed convincing staining of endogenous proteins, but we could not detect co-localization with poly-GR in *C9orf72* patients ([Fig S5A](#figS5){ref-type="fig"}; see the Materials and Methods section).

![Poly-GR does not show co-localization with tested interactors in *C9orf72* patient brain.\
**(A)** Immunofluorescent stainings of the frontal cortex of a *C9orf72* patient and a healthy control case to analyze co-localization of poly-GR with the interacting proteins GTPBP4, NOP56, PRMT1, WDR77, MAGOHB, and TRA2A.](LSA-2018-00070_FigS5){#figS5}

Thus, among the tested poly-GR/PR--interacting proteins, STAU2 and the cytosolic ribosome seems to be the most relevant co-aggregating protein (complex) in *C9orf72* patients.

Poly-PR reduces cytosolic ribosome levels and inhibits overall translation {#s8}
--------------------------------------------------------------------------

Given the wide-spread interaction of poly-GR/PR with ribosomes and other RNA-binding proteins, we also analyzed global protein expression using quantitative LC-MS/MS in poly-GR/PR--transduced primary neurons. GFP-(GR)~149~ transduction had no overt effect on the neuronal proteome and expression levels of none of its interactors were significantly altered ([Fig S6A](#figS6){ref-type="fig"}, red dots). Strikingly, (PR)~175~-GFP expression significantly affected expression of hundreds of proteins compared with the GFP control. These changes were much larger than mRNA expression changes reported recently ([@bib15]), supporting a primary effect of poly-PR on translation. These findings are consistent with the selective toxicity of (PR)~175~-GFP compared with GFP-(GR)~149~ observed in our culture system ([Fig S1C](#figS1){ref-type="fig"}). GO annotation analysis revealed overall reduction of cytosolic ribosomal proteins, which may explain the strong down-regulation of synaptic and axonal proteins ([Fig S6B](#figS6){ref-type="fig"}). In contrast, the levels of nucleolar and mitochondrial proteins were slightly increased. Overall, stress granule proteins ([Fig S6B](#figS6){ref-type="fig"}) and poly-GR/PR interactors ([Fig S6A](#figS6){ref-type="fig"}) were not affected. Despite the few large individual changes in the proteome of poly-GR--expressing cells, enrichment analysis shows a small but significant overall reduction of ribosomal proteins ([Fig S6B](#figS6){ref-type="fig"}), which is consistent with the interaction of poly-GR with ribosomal proteins in cellular models and patient brains ([Figs 1](#fig1){ref-type="fig"} and [5](#fig5){ref-type="fig"}).

![Poly-PR expression strongly affects the neuronal proteome.\
**(A)** Volcano plot showing individual proteins quantified in whole proteome of GFP-(GR)~149~-- and (PR)~175~-GFP--transduced primary cortical neurons from the same set used for interactome analysis in [Figs 1A](#fig1){ref-type="fig"} and [S2A](#figS2){ref-type="fig"}. The data for all proteins are plotted as log~2~-fold change versus the −log~10~ of the *P-*value. Significantly different proteins (q-value \< 5%) are highlighted as black dots. Proteins significantly enriched (q-value \< 5%) in the poly-GR/PR immunoprecipitates are shown in red. Transparent black and red dots denote proteins that are not significantly changed. **(B)** Volcano plot depicting enriched annotations (1D annotation enrichment) for respective proteome comparisons of GO terms (GOMF, GOCC, GOCC, GOPB, KEGG, UniProt keywords, stress granule proteins ([@bib12]), and proteins enriched in the neuronal poly-GR/PR interactome). Benjamini--Hochberg FDR--significant (q-value \< 5%) annotations are indicated in color or in black. The analysis was performed in Perseus software. Some dots with nearly identical position and annotation were removed for clarity. Related terms from the main pathways are labeled in the same color. Raw data are presented in Table S3.](LSA-2018-00070_FigS6){#figS6}

To substantiate this finding, we analyzed ribosomal protein expression in poly-PR/GR--expressing neurons by immunoblotting. Lentiviral poly-PR expression in primary neurons significantly reduced expression of ribosomal subunits RPS6, RPL19, and RPL36A, whereas cytoplasmic poly-GR expression had no strong effect ([Fig 6A and B](#fig6){ref-type="fig"}), despite the finding of subtle reduction by proteomics ([Fig S6B](#figS6){ref-type="fig"}). To investigate whether this loss of ribosomal components had an effect on total protein synthesis, we performed a surface sensing of translation (SUnSET) assay, which measures puromycin incorporation into newly synthesized proteins. After a brief pulse with puromycin, robust puromycin incorporation could be detected by immunoblotting with a puromycin-specific antibody. Importantly, the poly-PR--induced loss of ribosomal subunits was accompanied by a comparable reduction in overall protein synthesis compared with the GFP control, suggesting that the reduction of individual ribosomal subunits reflects a loss of functional ribosomes ([Fig 6C and D](#fig6){ref-type="fig"}).

![Poly-PR inhibits translation in neurons.\
Primary rat cortical neurons (DIV6 + 7) were transduced with GFP, GFP-(GR)~149~, or (PR)~175~-GFP lentivirus. **(A)** Immunoblots show reduced expression of several ribosomal proteins in (PR)~175~-GFP--expressing neurons. Calnexin was used as loading control. **(B)** Quantification of RPS6 signal normalized to calnexin (n = 6 from three independent experiments, mean ± SEM, exact *P*-values: GFP versus GFP-GR~149~, *P* = 0.1101 and GFP versus PR~175~-GFP, *P* = 0.0010 in one-way ANOVA with Dunnett's posttest), RPL19 signal normalized to calnexin (n = 6 from three independent experiments, mean ± SEM, exact *P*-values: GFP versus GFP-GR~149~, *P* = 0.1863 and GFP versus PR~175~-GFP, *P* = 0.0001 in the Kruskal--Wallis test with Dunn's posttest), and RPL36A signal normalized to calnexin (n = 6 from three independent experiments, mean ± SEM, exact *P*-values: GFP versus GFP-GR~149~, *P* = 0.1487 and GFP versus PR~175~-GFP, *P* = 0.0013 in the Kruskal--Wallis test with Dunn's posttest). **(C)** To quantify global translation, primary neurons were incubated with 1 μM puromycin (puro) for 0, 10, and 20 min before sample preparation, which is incorporated into truncated proteins (SUnSET system). A puromycin-specific antibody shows reduced levels of newly synthesized proteins in poly-PR--expressing neurons. Immunoblot for RPS6 and calnexin used as loading control. **(D)** Quantification of RPS6 signal normalized to calnexin (n = 3, mean ± SEM, Kruskal--Wallis test with Dunn's posttest, exact *P*-values: GFP versus GFP-GR~149~, *P* = 0.9999 and GFP versus PR~175~-GFP, *P* = 0.0507) and puromycin signal normalized to calnexin (n = 6, mean ± SEM, one-way ANOVA with Dunnett's posttest, exact *P*-values: GFP versus GFP-GR~149~, *P* = 0.2265 and GFP versus PR~175~-GFP, *P* = 0.0001).](LSA-2018-00070_Fig6){#fig6}

Thus, poly-PR and to a lesser extent GFP-(GR)~149~ expression leads to an overall reduction of cytosolic ribosomes, which results in a significant reduction of overall translation on poly-PR expression.

Nucleolar poly-GR expression impairs translation and nucleolar structure and enhances toxicity {#s9}
----------------------------------------------------------------------------------------------

Numerous groups have reported poly-GR toxicity in various model systems, including primary neurons ([@bib40]); these reports mostly used constructs with 20--100 repeats and typically involved predominantly nucleolar poly-GR localization, like we had observed in HEK293 cells, where we noticed slowed growth comparable with (PR)~175~-GFP--expressing cells ([Fig S1](#figS1){ref-type="fig"}). Thus, we asked whether lack of nucleolar localization for GFP-(GR)~149~ in primary neurons despite a significant overlap of interacting proteins with (PR)~175~-GFP might explain these discrepancies. Therefore, we truncated our GFP-(GR)~149~ construct resulting in GFP-(GR)~53~ and then analyzed its localization in primary neurons. GFP-(GR)~53~ showed diffuse cytoplasmic localization and strong localization in the nucleolus of 77.5% of the transduced neurons ([Fig 7A](#fig7){ref-type="fig"}). GFP-(GR)~53~ also induced neuronal death compared with GFP control, although less effectively than (PR)~175~-GFP ([Fig 7B](#fig7){ref-type="fig"}).

![Nucleolar poly-GR/PR alter nucleolar organization and inhibit translation.\
GFP, GFP-(GR)~53~, GFP-(GR)~149~, or (PR)~175~-GFP were transduced in primary rat neurons. **(A)** Images show fibrillarin immunofluorescence staining of hippocampal neurons. Left two columns represent GFP signal and fibrillarin staining in different DPR species as indicated. Right column shows merge with additional nuclear DAPI staining in blue. Scale bar denotes 20 μm. **(B)** LDH release assay detects significant cell death on lentiviral expression of (PR)~175~-GFP and GFP-(GR)~53~ but not GFP-(GR)~149~ compared with GFP control in primary rat neurons (DIV7 + 14) (n = 3 independent experiments with six replicates each; box plot is shown with 25th percentile, median, and 75th percentile; and whiskers represent minimum and maximum; exact *P*-values: GFP versus GFP-GR~53~, *P* = 0.0011; GFP versus GFP-GR~149~, *P* = 0.9954; and GFP versus PR~175~-GFP, *P* = 0.0001 in one-way ANOVA with Dunnett's posttest). **(C)** SUnSET experiment in GFP-(GR)~53~--, GFP-(GR)~149~--, (PR)~175~-GFP--, or GFP--expressing primary cortical neurons (DIV6+7) as in [Fig 6C](#fig6){ref-type="fig"}. Cells were incubated with 1 μM puromycin (puro) for 10 min or not treated (nt). Note the reduced incorporation of puromycin in neurons expressing GFP-(GR)~53~ and (PR)~175~-GFP. **(D)** Quantification of puromycin signal normalized to calnexin (n = 6 from three independent experiments, mean ± SEM, exact *P*-values: GFP versus GFP-GR~53~, *P* = 0.0022; GFP versus GFP-GR~149~, *P* = 0.8638; and GFP versus PR~175~-GFP, *P* = 0.0005 in one-way ANOVA with Dunnett's posttest). **(E)** Quantification of fibrillarin distribution within the nucleolus from (A). n = 6 to 16 images were analyzed.](LSA-2018-00070_Fig7){#fig7}

Moreover, lentiviral GFP-(GR)~53~ expression also significantly reduced the expression of the ribosomal subunit RPS6 and protein synthesis similar to (PR)~175~-GFP, whereas GFP-(GR)~149~ had no effect, suggesting that nucleolar poly-GR/PR expression interferes with ribosomal biogenesis resulting in impaired translation and poly-GR/PR in vitro toxicity ([Fig 7C and E](#fig7){ref-type="fig"}). Because acute GFP-(GR)~53~ toxicity is still weaker than poly-PR toxicity, we additionally analyzed nucleolus organization using immunofluorescence of fibrillarin ([Fig 7A and D](#fig7){ref-type="fig"}). In GFP-(GR)~149~-- and GFP--expressing neurons, most nucleoli showed homogenous staining of fibrillarin. In contrast, GFP-(GR)~53~ expression led to a ring-like fibrillarin distribution and occasionally to a granular pattern, which was even more pronounced in (PR)~175~-GFP--expressing neurons. Thus, nucleolar localization may promote the acute toxicity of poly-GR/PR seen in vitro.

Discussion {#s10}
==========

We analyzed poly-GR/PR interactors in primary neurons and C9orf72 brains to address the disconnect between acute toxicity in various model systems and prodromal expression decades before clinical symptoms in patients. In primary neurons, poly-GR and poly-PR interact with RNA-binding proteins, including many components of the nucleolus, stress granules, and the ribosome. Overexpression of the interactors NPM1 and STAU1/2 reroutes poly-GR into the nucleolus or large stress granule--like structures in vitro, respectively. Poly-GR/PR toxicity in vitro depends on nucleolar localization and structural alterations of the nucleolus. Direct binding of ribosomes and/or impaired ribosomal biogenesis in the nucleolus likely contributes to impaired translation. Importantly, we detected ribosomal proteins in the pathognomonic neuronal cytosolic poly-GR/PR inclusions in *C9orf72* patients, suggesting that milder effects on translation may drive the slower neurodegeneration seen in patients.

Poly-GR/PR interactome {#s11}
----------------------

We analyzed the interactome of poly-GR/PR in transduced rat cortical neurons and transfected HEK293 cells using GFP-(GR)~149~ and (PR)~175~-GFP baits. The repeat length of our constructs is still shorter than the repeats seen in patients but significantly longer than in previous studies using mainly pull-down with 20-mer or 30-mer peptides ([@bib14]; [@bib18]; [@bib1]; [@bib41]) or recombinant expression of (GR)~50~, (GR)~80~, and (PR)~50~ in cell lines ([@bib17]; [@bib19]). Moreover, the predominant cytoplasmic localization of GFP-(GR)~149~ more accurately reflects the patient situation. Similar to the peptide-based studies, we identified a large number of RNA-binding proteins, in particular components of the cytosolic and mitochondrial ribosome, stress granules, the nucleolus, and (especially in poly-PR) splicing factors. A large fraction of proteins contains low-complexity domains associated with phase separation properties ([@bib17]; [@bib18]; [@bib1]).

It is striking that GFP-(GR)~149~ and (PR)~175~-GFP constructs interacted mostly with overlapping proteins but showed dramatically different toxicity in LDH release assays and effects on proteome composition. Quantitative comparison of the poly-GR and poly-PR interactomes is confounded by the different localization of poly-GR in HEK293 cells and primary neurons. Nevertheless, the methylosome (PRMT5/WDR77), a component of the signal recognition particle (SRP72), and a stress granule marker (G3BP2) are specifically associated only with poly-GR in both cell types according to the most stringent criteria. GO analysis of pathways ([@bib37]) enriched in both poly-GR interactomes further highlights the role of cytosolic translation in poly-GR toxicity. In patients, differential analysis of poly-GR/PR toxicity is difficult because poly-PR almost completely co-aggregates with poly-GR ([@bib25]). Although poly-PR interactors in neurons and HEK293 cells were distinct, GO analysis shows a clear enrichment of splicing factors in both cell types, which is consistent with reported effects on splicing ([@bib16]). In primary neurons, enrichment analysis for poly-PR is additionally confounded by strong down-regulation of many proteins including ribosomal subunits. Interestingly, yeast screens also identified vastly different modifiers for poly-GR and poly-PR ([@bib13]; [@bib3]). Unexpectedly, knockout of several nonessential ribosomal subunits rescued poly-GR toxicity in yeast, but whether this may be primarily caused by reduced poly-GR expression was not addressed.

Poly-GR/PR interactions with stress granules and the nucleolus {#s12}
--------------------------------------------------------------

None of the previous interactome studies has reported co-aggregation of binding partners in poly-GR/PR inclusions in patients but focused their validation efforts on the effect of poly-GR/PR on the dynamics of membrane-less organelles, such as stress granules and the nucleolus ([@bib17]; [@bib1]). Here, we addressed how the interactors affect poly-GR/PR, as phase separation could lead to aggregation of poly-GR/PR or the interacting proteins ([@bib33]).

Previously, the interactors STAU1/2 and YBX1 have been found in stress granules by co-localization analysis and proteomics ([@bib35]; [@bib34]; [@bib12]). The dsRNA-binding proteins STAU1/2 are key components of RNA transport granules and help to dissolve stress granules in the recovery phase ([@bib35]), which may be impaired by binding to poly-GR/PR. In addition, YBX1 was found to promote stress granule formation indirectly through induction of G3BP1 translation ([@bib34]). Here, we report that co-expression of STAU1/2 and YBX1 leads to formation of large cytoplasmic stress granule--like poly-GR/PR clusters. Whether the DPR proteins are recruiting stress granule proteins or the other way around is not clear. The poly-PR interactor EIF4A3 was also found in stress granules but had no effect on poly-GR/PR localization. Surprisingly, we could detect only STAU2 but not YBX1 or classical stress granule markers (G3BP1 and TIAR) in the poly-GR aggregates in *C9orf72* patients, suggesting that STAU2 binding may contribute to aggregation of poly-GR/PR aggregates in vivo. Moreover, interaction of poly-GR/PR with stress granule proteins may affect translation indirectly ([@bib17]). We cannot exclude that other RNA-binding proteins interacting with poly-GR/PR contribute to the reduced translation.

Poly-GR/PR interact with several key nucleolar proteins, including NPM1 and NOP56. Overexpression of NPM1 recruited the predominantly cytosolic GFP-(GR)~149~ into the nucleolus in primary neurons, whereas NOP56 had no such effect. Importantly, NPM1 was shown to induce phase separation of (GR)~20~ and (PR)~20~ in vitro ([@bib17]). Super-resolution microscopy shows that poly-GR/PR specifically localize to the NPM1-positive liquid-like granular component of the nucleolus ([@bib17]). Our finding that nucleolar poly-(GR)~53~ and especially poly-PR alter the distribution of fibrillarin and NOP56 within the nucleolus suggests that nucleolar poly-GR/PR may interfere with ribosomal biogenesis in vitro, which depends on NOP56 ([@bib10]). Importantly, nucleolar localization has not been detected for any DPR species in patients ([@bib31]; [@bib38]) and the longer GFP-(GR)~149~ localizing predominantly to the cytoplasm was not acutely toxic. However, poly-GR--bearing neurons in patients have larger nucleoli ([@bib24]), suggesting that more subtle nucleolar effects may be at play in patients. Investigating nucleolar organization in patient tissues may be rewarding.

[@bib17] performed epistasis experiments with a large number of poly-GR/PR interactors originally identified in HEK293 cells using RNAi-mediated knockdown in flies. Interestingly, NPM1 knockdown reduced poly-GR toxicity in flies, whereas G3BP1 knockdown strongly enhanced poly-GR toxicity. Although they did not analyze poly-GR localization or aggregation under these conditions, the data are consistent with our hypothesis that poly-GR/PR in the nucleolus is most toxic by inhibiting ribosomal biogenesis, whereas sequestration of poly-GR/PR in stress granules may even be somewhat protective.

Poly-GR/PR bind ribosomes and inhibit translation {#s13}
-------------------------------------------------

We could detect the down-regulation of ribosomal proteins in poly-PR and to a lesser extent in GFP-(GR)~149~--expressing neurons ([Figs 6](#fig6){ref-type="fig"} and [S6](#figS6){ref-type="fig"}), leading to reduced translation efficiency (SUnSET assay) and an overall loss of structural proteins and cell death in poly-PR--expressing neurons. Strikingly, the shorter GFP-(GR)~53~ variant, which localized to the nucleolus, was toxic and strongly reduced ribosome levels in neurons. The reduced levels of ribosomal proteins and the altered organization of the nucleolus suggest that poly-GR/PR toxicity in vitro is due to impaired ribosomal biogenesis. However, the neuronal interactome of cytoplasmic GFP-(GR)~149~ strongly indicates that at least poly-GR also binds already-assembled ribosomes. Two recent proteomics studies have reported predominant interaction of (GR)~20~, (GR)~80~, and (PR)~20~ with cytosolic and mitochondrial ribosomes ([@bib14]; [@bib19]) but have not analyzed patient tissue. Here, we detected robust co-localization of several ribosomal proteins with ∼30% of cytoplasmic inclusions in *C9orf72* patients, highlighting the physiological significance of the ribosomal pathway for *C9orf72* pathogenesis. The next important step will be to directly show reduced translation in a mouse model or patient tissue depending on poly-GR/PR inclusions.

In addition, direct binding of poly-GR/PR to mRNA may inhibit ribosomal access and thus translation ([@bib14]), but stronger inhibition of translation by nucleolar GFP-(GR)~53~ than cytoplasmic GFP-(GR)~149~ argues against this hypothesis. A recent transcriptomics study reported slightly reduced expression of many ribosomal proteins in poly-PR--expressing neurons, consistent with reduced ribosomal biogenesis ([@bib15]). Because toxicity depends on nucleolar localization and reduction of ribosomal proteins, we propose that poly-GR/PR mainly interferes with ribosomal assembly/availability, but we cannot exclude additional effector mechanisms because translation is regulated at many levels. Also, the interaction of purified poly-GR/PR and ribosomes should be analyzed in greater detail using biophysical methods. It will be interesting to test whether restoring translation genetically or pharmacologically rescues poly-PR toxicity.

Conclusion {#s14}
----------

Several hypotheses have been put forward to explain the toxicity of arginine-rich DPR proteins in various model systems, including impaired nucleocytoplasmic transport ([@bib13]), oxidative stress ([@bib19]), interference with membrane-less organelles ([@bib17]; [@bib18]; [@bib1]), impaired splicing ([@bib16]; [@bib18]), and translation ([@bib14]). From our findings, using poly-GR constructs of different length, it seems that altered nucleolar organization and impaired ribosomal biogenesis may be the most important mechanism of acute toxicity in vitro. Our discovery of several ribosomal proteins in cytoplasmic DPR inclusions in patient brains suggests that translation may be impaired by direct binding in vivo. Because poly-GR/PR inclusions are found many years before disease onset in a stage with moderate prodromal brain atrophy ([@bib28]; [@bib38]), the effects are most likely less acute than in most in vitro systems. Moreover, recruitment of poly-GR/PR into large stress granule--like structures by overexpression of some interactors with low-complexity domains and detection of STAU2 in patient aggregates suggests that phase separation may be a relevant driver of DPR aggregation. In particular, differential expression of poly-GR/PR interactors may, therefore, explain regional neurodegeneration despite widespread DPR expression. Overall, trapping of ribosomes in poly-GR/PR inclusions is the most direct link between poly-GR/PR in vitro toxicity and patient neuropathology and suggests a role of impaired translation in *C9orf72* pathogenesis.

Materials and Methods {#s15}
=====================

DNA constructs and viral packaging {#s16}
----------------------------------

Synthetic genes with alternative codons for DPR sequences (GFP-(GR)~53~, GFP-(GR)~149~, and (PR)~175~-GFP) containing an ATG start codon were subcloned into a pEF6/V5-His vector (Life Technologies) or a lentiviral vector driven by the human synapsin promoter (FhSynW2) ([@bib22]). GFP from pEGFP-N1 (Clontech Laboratories) was used as negative control and subcloned into the respective vectors. Poly-GR/PR--interacting proteins were fused to the C-terminus of tagRFP by subcloning into FU3a-tagRFP. Empty vector was used as a control. Lentiviruses were packaged in human embryonic kidney cells (HEK293FT; Life Technologies) as described previously ([@bib32]).

Cell culture, transfection, and transduction {#s17}
--------------------------------------------

HEK293FT cells were cultivated in DMEM with Glutamax (Life Technologies) supplemented with 10% FCS, 1% Penicillin/Streptomycin, and 1% non-essential amino acids at 37°C with 5% CO~2~. Cells were transfected with Lipofectamine 2000 (Invitrogen) following the manufacturer's instructions.

Primary cortical and hippocampal neurons were cultured from embryonic day 19 Sprague--Dawley rats and cultivated in Neurobasal Medium (Life Technologies) supplemented with 2% B27 (Life Technologies), 1% Pen/Strep, and 2 mM Glutamine. Primary neurons were transduced at 7 days in vitro (DIV7) using specified lentiviruses.

SUnSET assay and immunoblotting {#s18}
-------------------------------

To analyze total protein synthesis, a SUnSET assay was performed. Therefore, primary cortical neurons were treated with 10 μg/ml puromycin (Merck) for 10 min at 37°C and 5% CO~2~.

For immunoblotting experiments, neurons were harvested in 2× Laemmli buffer 7 days after transduction (DIV7 + 7). Samples were incubated at 95°C for 5 min and run on a 12% SDS--PAGE or 10%--20% tricine gels (Novex). The following primary antibodies were used for immunoblotting: anti-calnexin (ADI-SPA-860F; Enzo Life Technologies), anti-puromycin (clone 12D10, MABE343; Merck Millipore), anti-RPS6 (sc-74459; Santa Cruz Biotechnology), anti-RPL19 (sc-100830; Santa Cruz Biotechnology), and anti-RPL36A (sc-100831; Santa Cruz Biotechnology). For quantitative analysis, ImageJ was used and statistical analysis was done using the GraphPad Prism (version 7.01) software.

Immunostaining and imaging in cell culture {#s19}
------------------------------------------

For immunostaining, cells grown on PDL-coated glass coverslips were fixed with 4% paraformaldehyde for 15 min and permeabilized (0.2% Triton X-100 and 50 mM NH~4~Cl in PBS) for 5 min. After blocking (30 min, 2% fetal bovine serum, 2% serum albumin, and 0.2% fish gelatin in PBS), the coverslips were incubated in primary antibody solution at RT for 1 h and washed with PBS. Finally, the cells were incubated in Alexa-coupled secondary antibody solution and treated with DAPI or TO-PRO-3 for staining of the nuclei. Antibodies and reagents used were anti-RPS6 (sc-74459; Santa Cruz Biotechnology), anti-G3BP1 (ab181150; Abcam), anti-fibrillarin (ab5821; Abcam), DAPI (Roche Applied Science), and TO-PRO-3 (Thermo Fisher Scientific). Single-plane images were obtained on a confocal laser scanning LSM710 microscope (Carl Zeiss) with a 63× or 40× immersion objective. Image editing and particle analysis was carried out using ImageJ software, and for statistical analysis, GraphPad Prism (version 7.01) software was used.

Patient samples and immunofluorescence patient stainings {#s20}
--------------------------------------------------------

All patient materials were provided by the Neurobiobank Munich, Ludwig Maximilians University of Munich. Paraffin-embedded brain sections were deparaffinated and rehydrated with xylene and ethanol. To retrieve the antigen, slides were boiled 4× for 5 min in 100 mM citrate buffer of pH 6.0 using a microwave. After a brief rinse with deionized water, the sections were washed in PBS/0.05% Brij35, followed by blocking with 2% fetal calf serum in PBS for 5 min. The tissue was incubated overnight at 4°C in primary antibody solution. The following antibodies were used: STAU2 (ab60724; Abcam), anti-YBX1 (ab12148; Abcam), anti-FMRP (ab17722; Abcam), anti-G3BP2 (ab86135; Abcam), anti-TIAR (sc-136266; Santa Cruz Biotechnology), anti-RPS6 (sc-74459; Santa Cruz Biotechnology), anti-RPL19 (sc-100830; Santa Cruz Biotechnology), anti-RPS25 (HPA031801; Atlas Antibodies), anti-RPL36A (sc-100831; Santa Cruz Biotechnology), anti-GTPBP4 (ab184124; Abcam), anti-NOP56 (HPA049918; Atlas Antibodies), anti-PRMT1 (ab73246; Abcam), anti-WDR77 (HPA027271; Atlas Antibodies), anti-MAGOHB (ab186431; Abcam), anti-TRA2A (ab72625; Abcam), anti-GR clone 7H1 detecting predominantly non-methylated and asymmetrically dimethylated poly-GR ([@bib31]), anti-PR clone 32B3 raised against non-methylated poly-PR ([@bib31]), and rabbit polyclonal ([@bib25]). Afterward, sections were washed twice in PBS/0.05% Brij35 before incubation with Alexa-coupled secondary antibodies for 1 h at RT. Next, the sections were washed again, treated with DAPI for 15 min, and washed twice in PBS/0.05% Brij35 and twice in PBS only. The tissue was incubated in Sudan Black for 1 min at RT, rinsed in PBS, and mounted with Fluoromount Aqueous Mounting Medium (Merck).

Antibodies for poly-GR/PR that did not show convincing staining in brain sections were anti-CCDC40 (ab121727; Abcam), anti-PABPC4 (ab101492; Abcam), anti-MRPS9 (ab187906; Abcam), anti-MRPS11 (HPA050345; Atlas Antibodies), anti-MRPS23 (ab154533; Abcam), anti-MRPL12 (ab58334; Abcam), anti-PRMT5 (ab31751; Abcam), anti-CAPZA (ab166892; Abcam), anti-MOV10 (ab60132; Abcam), anti-ODZ3 (ab198923; Abcam), anti-SH3KBP (ab151574; Abcam), anti-TRA2B (ab66901; Abcam), anti-NDUFS3 (ab110246; Abcam), anti-SRP72 (PA5-56994; Thermo Fisher Scientific), anti-SNRPD3 (ab121129; Abcam), and anti-SNRPD2 (PA5-27547; Invitrogen).

Viability of primary neurons and HEK293FT cells {#s21}
-----------------------------------------------

Toxicity assays in transduced primary cortical neurons (DIV7 + 14) and HEK293FT cells were performed in 96-well plates using the LDH Cytotox Non-Radioactive Cytotoxicity Assay (Promega) following the manufacturer's instructions. To assess cell viability in HEK293FT cells, an XTT (Roche) assay was used according to the manufacturer\'s protocols. Cells were cultivated in a 96-well plate. Absorption was measured after 24-h incubation time. Statistical analysis was performed using GraphPad Prism (version 7.01) software.

Immunoprecipitation of poly-GR and poly-PR aggregates in neurons and HEK293FT {#s22}
-----------------------------------------------------------------------------

Quadruplicates of GFP-(GR)~149~--, (PR)~175~-GFP--, or GFP-infected cortical neurons (DIV7 + 8) and transfected HEK293FT cells were harvested in Benzonase Nuclease (Sigma) containing lysis buffer (2% Triton X-100, 750 mM NaCl, and 1 mM KH~2~PO~4~). Cell lysates were rotated for 45 min at 4°C. 10% was kept for whole proteome analysis, whereas the remaining samples were centrifuged at 1,000 *g* for 5 min at 4°C. With GFP antibody (clone N86/38; Neuromab), preincubated Protein G Dynabeads (Life Technologies) were added to the rest of the supernatant and incubated for 3 h at 4°C. After three washing steps (in 150 mM NaCl, 50 mM Tris, pH 7.5, and 5% Glycerol), they were used for further sample preparation for mass spectrometry analysis.

LC-MS/MS {#s23}
--------

Peptides were separated on an EASY-nLC 1000 HPLC system (Thermo Fisher Scientific) via in-house packed columns (75-μm inner diameter, 30-cm length, and 1.9-μm C18 particles \[Dr. Maisch GmbH\]) in a gradient of buffer A (0.5% formic acid in H~2~O) to buffer B (0.5% formic acid in H~2~O and 80% acetonitrile) at 300 nl/min flow rate. For IPs, we increased the content of buffer B from 2% to 30% 85 min before increasing the concentration of buffer B to 95% to wash the column. For complete proteomes, we increased the content of buffer B from 5% to 30% 155 min before increasing the concentration of buffer B to 95% to wash the column. The column temperature was set to 60°C. A Quadrupole Orbitrap mass spectrometer (Scheltema et al, 2014) (Q Exactive HF; Thermo Fisher Scientific) was directly coupled to the LC via nano-electrospray source. The Q Exactive HF was operated in a data-dependent mode. The survey scan range was set from 300 to 1,650 *m*/*z*, with a resolution of 60,000 at *m*/*z* 200. Up to the 15 most abundant isotope patterns with a charge greater than or equal to two were subjected to collision-induced dissociation fragmentation at a normalized collision energy of 27, an isolation window of 1.4 Th, and a resolution of 15,000 at *m*/*z* 200. Dynamic exclusion to minimize resequencing was set to 30 s (proteome) or 20 s (IP). Data were acquired using Xcalibur software (Thermo Fisher Scientific).

MS data analysis and statistics {#s24}
-------------------------------

To process MS raw files, we employed the MaxQuant software (v 1.5.3.54 for HEK data and 1.5.4.3 for neuron data) ([@bib5]) and Andromeda search engine ([@bib6]), against the UniProtKB rat FASTA database (08/2015) and UniProtKB human FASTA database (08/2015), respectively, using default settings. Enzyme specificity was set to trypsin, allowing cleavage N-terminally to proline and up to two mis-cleavages. Carbamidomethylation was set as fixed modification, and acetylation (N terminus) and methionine oxidation were set as variable modifications. A false discovery rate (FDR) cutoff of 1% was applied at the peptide and protein level. For rat neuron data, the FDR was independently calculated and applied for IP samples and complete proteomes by setting individual parameter groups in MaxQuant. "Match between runs," which allows the transfer of peptide identifications in the absence of sequencing after nonlinear retention time alignment, was enabled with a maximum retention time window of 0.7 min. Protein identification required at least one razor peptide. Data were filtered for common contaminants (n = 247). Peptides only identified by site modification were excluded from further analysis. Proteins were normalized with MaxLFQ label-free normalization ([@bib4]). The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository with the dataset identifier PXD008691 ([@bib39]).

For bioinformatic analysis and visualization, we used the open PERSEUS (v 1.5.2.12, 1.5.3.4, 1.5.4.2, 1.5.5.5, and 1.5.8.7) environment ([@bib37]), MaxQuant (neurons: 1.5.4.3 and HEK: 1.5.3.54), and the R framework (Team, R Development Core, 2008). Imputation of missing values was performed with a normal distribution (width = 0.3 and shift = 1.8). For pairwise comparison of proteomes and determination of significant differences in protein abundances, *t* test statistics were applied with a permutation-based FDR of 5% and S0 of 1 ([@bib36]), requiring at least 66% valid values in at least one group per comparison. For the 1D and 2D annotation, we first matched GO data (GOMF name, GOCC name, GOCC slim name, GOBP slim name, and Kegg and UniProt keywords) to the protein identifiers (major ID) in Perseus. Moreover, the annotation for stress granule proteins identified by [@bib12] for humans was assigned both for HEK and rat neuron data. Stress granule annotations were transferred from human to rat for genes with identical gene names in both species. The 1D and 2D annotation enrichment was performed on the Welch's *t* test difference in the Perseus environment. FDR control was performed using the Benjamini--Hochberg correction separately within each annotation category, e.g., GOCC or GOBP. Accordingly, the FDR cutoff (q-value \< 5%) relates to slightly different *P*-values in the different annotation categories, thereby leading to significant (black) and insignificant (gray) populations slightly overlapping in the --log~10~ (*P*-value) dimension in the 1D annotation plots ([Fig S6B](#figS6){ref-type="fig"}). The 2D annotation plots show annotation terms with q-values \< 0.1. Both 1D and 2D annotation terms were filtered for terms comprising at least six proteins quantified by mass spectrometry.

We assessed the content of low complexity in the neuronal interactome based on IUPred-L ([@bib8]). We queried all proteins detected in the neuronal interactome data (see filtering criteria), significant poly-PR interactors, and significant poly-GR interactors in D2P2 ([@bib27]). Queries were based on MaxQuant reported UniProt identifier, using the first entry if multiple identifiers were reported in protein groups. For determining significant differences, we employed the Mann--Whitney--Wilcoxon test.
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Supplementary Information is available at [https://doi.org/10.26508/lsa.201800070](https://doi.org/10.26508/lsa.201800054).
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